# Revelation Biosciences, Inc.: Form DEF 14A, filed Feb 17, 2026

- Company: [Revelation Biosciences, Inc.](/companies/revb.md) (CIK 1810560)
- Form: DEF 14A
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 12:35 ET
- Period: 2026-02-14
- Accession: 0001193125-26-053984
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1810560/000119312526053984/revb-20260214.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810560/000119312526053984/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810560/000119312526053984/revb-20260214.htm

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-053984. Last ingested by Listed: Nov 14, 2026, 13:36 ET. No prices; not investment advice.
